These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery. Thomas CE, Will Y. Expert Opin Drug Discov; 2012 Feb 23; 7(2):109-22. PubMed ID: 22468913 [Abstract] [Full Text] [Related]
17. Integrating molecular design resources within modern drug discovery research: the Roche experience. Stahl M, Guba W, Kansy M. Drug Discov Today; 2006 Apr 23; 11(7-8):326-33. PubMed ID: 16580974 [Abstract] [Full Text] [Related]
18. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery. Therrien E, Englebienne P, Arrowsmith AG, Mendoza-Sanchez R, Corbeil CR, Weill N, Campagna-Slater V, Moitessier N. J Chem Inf Model; 2012 Jan 23; 52(1):210-24. PubMed ID: 22133077 [Abstract] [Full Text] [Related]
19. Virtual compound screening in drug discovery. Stumpfe D, Ripphausen P, Bajorath J. Future Med Chem; 2012 Apr 23; 4(5):593-602. PubMed ID: 22458679 [Abstract] [Full Text] [Related]
20. Bioinformatics platform development: from gene to lead compound. Ivanov AS, Veselovsky AV, Dubanov AV, Skvortsov VS. Methods Mol Biol; 2006 Apr 23; 316():389-431. PubMed ID: 16671411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]